Jens Ulrik Stæhr Jensen

Medicine & Life Sciences

1. Chronic Obstructive Pulmonary Disease 100%
2. Procalcitonin 51%
3. Adrenal Cortex Hormones 33%
4. Cohort Studies 33%
5. Mortality 30%
6. Anti-Bacterial Agents 28%
7. Denmark 27%
8. Biomarkers 27%
9. Critical Illness 26%
10. Randomized Controlled Trials 26%
11. Intensive Care Units 24%
12. Coronavirus 22%
13. Human Influenza 22%
14. Hospitalization 19%
15. Critical Care 16%
16. Therapeutics 16%
17. Vaccination 16%
18. Observational Studies 16%
19. Sepsis 16%
20. Asthma 15%
21. Influenza Vaccines 15%
22. Respiratory Insufficiency 14%
23. Hydroxychloroquine 14%
24. Acute Kidney Injury 14%
25. Respiratory Tract Infections 13%
26. Infections 12%
27. Pseudomonas aeruginosa 11%
28. Outpatients 11%
29. Oxygen 10%
30. Lung 10%
31. Confidence Intervals 10%
32. Lung Diseases 10%
33. Induced Hypothermia 10%
34. Azithromycin 9%
35. Placebos 9%
36. Neutralizing Antibodies 9%
37. Survival 9%
38. Guidelines 9%
39. Random Allocation 8%
40. Registries 8%
41. Pneumonia 8%
42. Noninvasive Ventilation 8%
43. Eosinophils 8%
44. Disease Progression 7%
45. Pandemics 7%
46. Heart Failure 7%
47. Septic Shock 7%
48. Pneumococcal Infections 6%
49. Point-of-Care Systems 6%
50. Water-Electrolyte Balance 6%